Vanglbaggetf (VAGU) News

Lucid Diagnostics Launches New Corporate Website

Lucid Diagnostics Launches New Corporate Website PR Newswire NEW YORK, July 11, 2024 NEW YORK, July 11, 2024...

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter Clinical Validation Study of EsoGuard® Esophageal Precancer Testing in a Screening Population

Lucid Diagnostics Announces Positive Data from its ESOGUARD BE-1 Prospective, International, Multicenter...

4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing

4,000th Firefighter Undergoes Lucid Diagnostics' EsoGuard® Esophageal Precancer Testing PR Newswire NEW YORK...

Form DEF 14A - Other definitive proxy statements

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form PRE 14A - Other preliminary proxy statements

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form 8-K - Current report

Form 8-K - Current report

PAVmed Provides Business Update and First Quarter 2024 Financial Results

PAVmed Provides Business Update and First Quarter 2024 Financial Results PR Newswire NEW YORK, May 13, 2024...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results PR Newswire NEW YORK, May...

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities